IDEAYA BIOSCIENCES INC's ticker is IDYA and the CUSIP is 45166A102. A total of 69 filers reported holding IDEAYA BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,484,386 | +5.6% | 55,018 | -8.0% | 0.00% | 0.0% |
| Q2 2023 | $1,405,723 | +103.6% | 59,818 | +19.0% | 0.00% | +100.0% |
| Q1 2023 | $690,358 | -25.6% | 50,281 | -1.6% | 0.00% | 0.0% |
| Q4 2022 | $928,233 | +32.0% | 51,086 | +8.4% | 0.00% | 0.0% |
| Q3 2022 | $703,000 | +33.4% | 47,138 | +23.5% | 0.00% | 0.0% |
| Q2 2022 | $527,000 | +27.0% | 38,155 | +2.9% | 0.00% | 0.0% |
| Q1 2022 | $415,000 | -56.8% | 37,086 | -8.6% | 0.00% | 0.0% |
| Q4 2021 | $960,000 | +112.9% | 40,588 | +129.3% | 0.00% | 0.0% |
| Q3 2021 | $451,000 | -44.5% | 17,700 | -54.3% | 0.00% | 0.0% |
| Q2 2021 | $812,000 | +29.7% | 38,694 | +45.3% | 0.00% | 0.0% |
| Q1 2021 | $626,000 | +85.8% | 26,627 | +10.5% | 0.00% | – |
| Q4 2020 | $337,000 | +11.2% | 24,100 | 0.0% | 0.00% | – |
| Q3 2020 | $303,000 | +17.4% | 24,100 | +32.9% | 0.00% | – |
| Q2 2020 | $258,000 | – | 18,133 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners X LLC | 2,660,713 | $29,774,000 | 30.23% |
| Logos Global Management LP | 2,850,000 | $31,892,000 | 4.14% |
| 5AM Venture Management, LLC | 1,398,066 | $15,644,000 | 3.42% |
| ACT CAPITAL MANAGEMENT, LLC | 173,500 | $1,941,000 | 2.05% |
| DAFNA Capital Management LLC | 490,061 | $5,484,000 | 1.43% |
| Boxer Capital, LLC | 2,202,812 | $24,649,000 | 1.27% |
| BVF INC/IL | 1,600,559 | $17,910,000 | 0.72% |
| Avidity Partners Management LP | 2,690,000 | $30,101,000 | 0.63% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 62,929 | $704,000 | 0.43% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 109,000 | $1,623,000 | 0.37% |